Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-05-19

FDA Approved: MESALAMINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA has approved Sun Pharmaceutical's supplemental application for mesalamine, likely resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)